Details

Autor(en) / Beteiligte

• Nurden, Paquita
• Debili, Najet
• Coupry, Isabelle
• Bryckaert, Marijke
• Youlyouz-Marfak, Ibtissam
• Solé, Guilhem
• Pons, Anne-Cécile
• Berrou, Eliane
• Adam, Frédéric
• Kauskot, Alexandre
• Lamazière, Jean-Marie Daniel
• Rameau, Philippe
• Fergelot, Patricia
• Rooryck, Caroline
• Cailley, Dorothée
• Arveiler, Benoît
• Lacombe, Didier
• Vainchenker, William
• Nurden, Alan
• Goizet, Cyril

Titel

Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome

Ist Teil von

• Blood, 2011-11, Vol.118 (22), p.5928-5937

Ort / Verlag

Washington, DC: Elsevier Inc

Erscheinungsjahr

2011

Quelle

MEDLINE

Beschreibungen/Notizen

• Filaminopathies A caused by mutations in the X-linked FLNA gene are responsible for a wide spectrum of rare diseases including 2 main phenotypes, the X-linked dominant form of periventricular nodular heterotopia (FLNA-PVNH) and the otopalatodigital syndrome spectrum of disorders. In platelets, filamin A (FLNa) tethers the principal receptors ensuring the platelet–vessel wall interaction, glycoprotein Ibα and integrin αIIbβ3, to the underlying cytoskeleton. Hemorrhage, coagulopathy, and thrombocytopenia are mentioned in several reports on patients with FLNA-PVNH. Abnormal platelet morphology in 2 patients with FLNA-PVNH prompted us to examine a third patient with similar platelet morphology previously diagnosed with immunologic thrombocytopenic purpura. Her enlarged platelets showed signs of FLNa degradation in Western blotting, and a heterozygous missense mutation in FLNA was detected. An irregular distribution of FLNa within the total platelet population was shown by confocal microscopy for all 3 patients. In vitro megakaryocyte cultures showed an abnormal differentiation, including an irregular distribution of FLNa with a frayed aspect, the presence of enlarged α-granules, and an abnormal fragmentation of the cytoplasm. Mutations in FLNA may represent an unrecognized cause of macrothrombocytopenia with an altered platelet production and a modified platelet–vessel wall interaction.